Analysis of yellow fever vaccination practice in England

Journal of Travel Medicine

Volumn 15, Issue 5, 2008, Pages 287-293

  Bryant, Naomi ^a   Tucker, Rosemary ^a,b   Simons, Hilary ^a,b   Bailey, Stella ^a   Mathewson, John ^a   Lea, Gil ^a   Hill, David R ^a,c,d  

^a National Travel Health Network and Centre   (United Kingdom)

^b LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

YELLOW FEVER VACCINE;

ARTICLE; CLINICAL PRACTICE; DATA BASE; DRUG INDUSTRY; DRUG STORAGE; EMPORIATRICS; GENERAL PRACTICE; HEALTH CARE DELIVERY; HEALTH CENTER; HEALTH PROGRAM; INTERNET; MEDICAL EDUCATION; MEDICAL INFORMATION; NURSE; PHYSICIAN; QUESTIONNAIRE; REGISTRATION; STANDARD; TRAVEL; UNITED KINGDOM; VACCINATION; YELLOW FEVER;

ATTITUDE OF HEALTH PERSONNEL; ENGLAND; FAMILY PRACTICE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PROMOTION; HUMANS; IMMUNIZATION PROGRAMS; PRACTICE GUIDELINES AS TOPIC; QUALITY OF HEALTH CARE; QUESTIONNAIRES; TRAVEL; VACCINATION; YELLOW FEVER; YELLOW FEVER VACCINE;

EID: 53749089696     PISSN: 11951982     EISSN: 17088305     Source Type: Journal    
DOI: 10.1111/j.1708-8305.2008.00217.x     Document Type: Article

References (21)

1. Barnett ED. Yellow fever: epidemiology and prevention. Clin Infect Dis 2007 44 : 850 856.
2. World Health Organization. International Health Regulations (1969). Geneva, Switzerland : World Health Organization, 1969.
3. World Health Organization. International Health Regulations (2005). Geneva, Switzerland : World Health Organization, 2005.
4. Hardiman M, Wilder-Smith A. The revised international health regulations and their relevance to travel medicine. J Travel Med 2007 14 : 141 144.
5. Leggat PA, Ross MH, Dürrheim DN, et al. Linking yellow fever vaccination centre registration and training in travel medicine. Travel Med Infect Dis 2003 1 : 17 18.
6. Spira A. Yellow fever vaccine as a vehicle to better travel medicine. J Travel Med 2005 12 : 303 305.
7. Beeching NJ, Hill DR. NaTHNaC - the National Travel Health Network and Centre (England) (Editorial). Travel Med Infect Dis 2003 1 : 123 125.
8. Hill DR. The NaTHNaC Yellow Fever Vaccination Centre (YFVC) initiative: a programme of registration, training, standards and audit 2008, London (On-line resource). Available at : http://www.nathnac.org/pro/yfvcinitiative.htm. (Accessed 2008 May 31)
9. Russell MN, Cetron MS, Eidex RB. The US-Certified Yellow Fever Vaccination Center Registry: a tool for travelers, state health departments, and vaccine providers. J Travel Med 2006 13 : 48 49.
10. Labelle C, Macpherson DW. Evaluation of yellow fever vaccination centers in Canada. J Travel Med 2005 12 : 180 183.
11. Carroll B, Behrens RH, Crichton D. Primary health care needs for travel medicine training in Britain. J Travel Med 1998 5 : 3 6.
12. Hoveyda N, McDonald P, Behrens RH. A description of travel medicine in general practice: a postal questionnaire survey. J Travel Med 2004 11 : 295 298.
13. Royal College of General Practitioners. Profile of UK practices, 2006 (On-line resource). Available at : http://www.rcgp.org.uk/pdf/ISS_INFO_02_MAY06. pdf. (Accessed 2008 May 31)
14. Monath TP, Cetron MS. Prevention of yellow fever in persons traveling to the tropics. Clin Infect Dis 2002 34 : 1369 1378.
15. Centers for Disease Control and Prevention. Health information for international travel 2008. Atlanta : US Department of Health and Human Services, Public Health Service, 2008.
16. World Health Organization. International travel and health. Geneva, Switzerland : World Health Organization Press, 2008.
17. Chan RC, Penney DJ, Little D, et al. Hepatitis and death following vaccination with 17D-204 yellow fever vaccine. Lancet 2001 358 : 121 122.
18. Kitchener S. Viscerotropic and neurotropic disease following vaccination with the 17D yellow fever vaccine, ARILVAX((R)). Vaccine 2004 22 : 2103 2105.
19. Marfin AA, Barwick Eidex RS, Kozarsky PE, Cetron MS. Yellow fever and Japanese encephalitis vaccines: indications and complications. Infect Dis Clin North Am 2005 19 : 151 168.
20. Khromava AY, Eidex RB, Weld LH, et al. Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events. Vaccine 2005 23 : 3256 3263.
21. McMahon AW, Eidex RB, Marfin AA, et al. Neurologic disease associated with 17D-204 yellow fever vaccination: a report of 15 cases. Vaccine 2007 25 : 1727 1734.